Support First Things by turning your adblocker off or by making a  donation. Thanks!

“Cloning research ‘clearly upsets the general public’ yet it has limited potential for treating disease and adds little to scientific understanding of human biology, according to Professor Austin Smith of the University of Cambridge...’Its prominence is out of proportion to the significance of what’s being done, and there are real question marks about whether it has any utility at all.”

Gee, really? I guess that is why this article in the London Times will never be published in the New York Times.


Comments are visible to subscribers only. Log in or subscribe to join the conversation.

Tags

Loading...

Filter First Thoughts Posts

Related Articles